SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
6-K
REPORT
OF
FOREIGN ISSUER
Pursuant
to Rule 13a-16 or 15d-16 of
the
Securities Exchange Act of 1934
For
the month of November 2005
Commission
File Number 000-51122
pSivida
Limited
(Translation
of registrant’s name into English)
Level
12
BGC Centre
28
The
Esplanade
Perth
WA
6000
(Address
of principal executive offices)
(Indicate
by check mark whether the registrant files or will file annual reports under
cover Form 20-F or Form 40-F).
Form
20-F
ý Form
40-F o
Indicate
by check mark if the registrant is submitting the Form 6-K in paper as permitted
by Regulation S-T Rule 101(b)(1):
Indicate
by check mark if the registrant is submitting the Form 6-K in paper as permitted
by Regulation S-T Rule 101(b)(7):
Indicate
by check mark whether the registrant by furnishing the information contained
in
this Form is also thereby furnishing the information to the Commission pursuant
to Rule 12g3-2(b) under the Securities Exchange Act of 1934.
Yes
o No
ý
If
"Yes"
is marked, indicate below the file number assigned to the registrant in
connection with Rule 12g3-2(b): 82- ___.
SIGNATURE
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant,
pSivida Limited, has duly caused this report to be signed on its behalf by
the
undersigned, thereunto duly authorized.
Date:
November 28, 2005
pSivida
Limited
By:
/s/
Aaron
Finlay
Aaron
Finlay
Chief
Financial Officer and Company Secretary
EXHIBIT
INDEX
EXHIBIT
99.1: Letter
from ASX, dated November 28, 2005, and response by pSivida
Limited.
The
attached exhibit contains forward-looking statements that involve risks and
uncertainties, including regarding our expectations in respect of trading
activity in pSivida’s securities. Although we believe that the expectations
reflected in such forward-looking statements are reasonable at this time,
we can
give no assurance that such expectations will prove to be correct. Given
these
uncertainties, readers are cautioned not to place undue reliance on such
forward-looking statements. Actual results could differ materially from those
anticipated in these forward-looking statements due to many important factors
including: our shareholders’ desire to divest of additional shares of our
securities for reasons related to or unrelated to our business or its
performance. We do not undertake to update any oral or written forward-looking
statements that may be made by or on behalf of pSivida.